[Hiring] Clinical Trials Associate @BioAge Labs

Role Description

BioAge is seeking a Clinical Trial Associate (Senior CTA) to join our Clinical Operations team. The CTA plays a critical role in the execution of Phase 1–3 clinical trials and is responsible for ensuring operational excellence, inspection readiness, and compliance with ICH/GCP guidelines and company SOPs. This position partners closely with Clinical Trial Managers, CROs, vendors, and investigative sites to support timely and high-quality study delivery.

Key Responsibilities

• Independently support and coordinate clinical trial activities from start-up through close-out.
• Partner with CTMs to ensure operational milestones, timelines, and deliverables are achieved.
• Serve as primary owner of Trial Master File (TMF) quality, completeness, and inspection readiness.
• Perform ongoing TMF quality control and resolve documentation gaps with internal teams and vendors.
• Collaborate with CROs, vendors, and sites to ensure study milestones and deliverables are met.
• Track study timelines, identify risks, and proactively escalate issues as needed.
• Support IRB/IEC submissions and review essential regulatory documents for compliance.
• Maintain accurate and timely data within clinical systems (eTMF, CTMS, EDC).
• Assist with development and review of key clinical documents, including protocols, informed consent forms and study plans/manuals.
• Support preparation, review, and tracking of IRB/IEC submissions and regulatory documentation.
• Coordinate and track laboratory samples from investigative sites to central and specialty laboratories, ensuring timely shipment, reconciliation, and documentation accuracy.
• Participate in internal and external meetings, including preparation of agendas, meeting minutes, and action item tracking.
• Prepare and manage study communications, including newsletters and study updates as needed.
• Contribute to audit and inspection preparation activities.

Qualifications

• Bachelor’s degree in a scientific or healthcare-related field preferred; equivalent experience considered.
• 2-3+ years of clinical operations experience in biotechnology, pharmaceutical, or CRO settings.
• Experience supporting Phase 1–3 clinical trials.
• Hands-on experience with TMF management and clinical systems (eTMF, CTMS, EDC).
• Working knowledge of ICH/GCP and applicable regulatory requirements.
• Strong organizational skills and exceptional attention to detail.
• Ability to manage multiple priorities in a fast-paced, collaborative environment.
• Excellent written and verbal communication skills.

Preferred Qualifications

• Experience in a small or early-stage biotech company.
• Experience supporting audit or regulatory inspection readiness.
• Experience working with global or multi-site clinical trials.
• Prior CRO oversight experience.

Benefits

• Competitive salary and comprehensive compensation package.
• Generous paid time off in addition to company-observed holidays.
• Comprehensive health and wellness benefits (medical, dental, and vision insurance).
• 401(k) retirement savings plan with matching employer contributions.
• Childcare and fertility benefits.
• Opportunities for career development, including a generous annual budget for continued learning.
• Many positions are remote, allowing team members to work from anywhere.
• Salary for this role is expected to be approximately $80,000 - 90,000, depending on experience.

Company Description

BioAge is a clinical-stage biopharmaceutical company harnessing the biology of human aging to develop new therapies for metabolic diseases. The Company’s human-first discovery platform analyzes proprietary multi-omics data captured over decades to identify molecular pathways that drive metabolic aging and disease. BioAge’s lead program, BGE-102, is a potent, orally available, brain-penetrant NLRP3 inhibitor being developed for cardiovascular risk and retinal diseases. The Company is also advancing oral and injectable APJ agonists—exercise mimetics with the potential to enhance incretin-driven weight loss and restore healthy body composition in obesity. BioAge’s discovery platform is validated by ongoing research collaborations with Novartis and Lilly. BioAge has been listed on Nasdaq (BIOA) since 2024.